Department of Pharmaceutics, Modern College of Pharmacy, Pune, Maharashtra, India.
Drug Deliv. 2013;20(1):40-6. doi: 10.3109/10717544.2012.752420.
A transdermal delivery system is warranted for repaglinide (RPG) which possesses half-life of 1 h and oral bioavailability of 56%. Ethosomes are useful tools for transdermal drug delivery.
To prepare and evaluate ethosomes as mode for transdermal delivery of RPG.
Ethosomes loaded with RPG were prepared from dipalmitoyl phosphatidylcholine and ethanol by the cold method. They were characterized using Fourier transform infrared spectroscopy and differential scanning calorimetry. They were evaluated for vesicle size, entrapment efficiency and ex-vivo skin permeation. Ethosomal composition was optimized using the 3(2) factorial design. Gel containing optimzsed ethosomes was studied for antidiabetic activity in rats.
RPG ethosomes possessing the size of 0.171-1.727 µm and entrapment efficiency of 75-92% were obtained. They demonstrated a significantly higher permeation (64-97% of the administered dose) across excised rat skin when compared to free drug and its hydro alcoholic solution. In-vivo, RPG ethosomal system caused sustained antidiabetic effect.
The lipid and ethanol concentration affected the physicochemical attributes and performance of ethosomes. The flexible ethosomes permeated the stratum corneum and improvized the availability of RPG for antidiabetic action. They prolonged the antidiabetic effect of RPG over a significantly longer period of time in comparison with the equivalent oral dose.
Ethosomal system can successfully deliver RPG transdermally; sustain its effect and thus reduce its dosing frequency. Ethosomes are useful for enhancing the efficacy of RPG in the treatment of diabetes.
瑞格列奈(RPG)半衰期为 1 小时,口服生物利用度为 56%,因此需要开发经皮给药系统。醇质体是经皮给药的有用工具。
制备并评价 RPG 的醇质体经皮给药系统。
采用冷法,以二棕榈酰磷脂酰胆碱和乙醇制备负载 RPG 的醇质体。采用傅里叶变换红外光谱和差示扫描量热法对其进行表征。考察其囊泡粒径、包封率和体外透皮性能。采用 3(2)析因设计优化醇质体组成。考察含优化醇质体的凝胶在大鼠体内的抗糖尿病活性。
得到粒径为 0.171-1.727 µm、包封率为 75-92%的 RPG 醇质体。与游离药物及其水醇溶液相比,其对离体大鼠皮肤的渗透显著增加(给药剂量的 64-97%)。在体内,RPG 醇质体系统可引起持续的抗糖尿病作用。
脂质和乙醇浓度影响醇质体的理化性质和性能。柔性醇质体渗透角质层,提高 RPG 用于抗糖尿病作用的生物利用度。与等效口服剂量相比,它们可显著延长 RPG 的抗糖尿病作用时间。
醇质体系统可成功经皮递运 RPG,持续其作用,从而减少其给药频率。醇质体可提高 RPG 治疗糖尿病的疗效。